<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>List of countries by annual cannabis use</title><meta name="description" content="The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/List_of_countries_by_annual_cannabis_use"/><meta property="og:title" content="List of countries by annual cannabis use"/><meta property="og:description" content="The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological..."/><meta property="og:url" content="https://grokipedia.com/page/List_of_countries_by_annual_cannabis_use"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="List of countries by annual cannabis use"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:43.339Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="List of countries by annual cannabis use"/><meta name="twitter:description" content="The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="77268c3b413f2cc938a8a41d95c511d8-a5678c031e39f13d-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=77268c3b413f2cc938a8a41d95c511d8,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.8062123521486737,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#list-of-countries-by-annual-cannabis-use" class="transition-opacity hover:opacity-100 opacity-50">List of countries by annual cannabis use</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#methodology-and-data-sources" class="transition-opacity hover:opacity-100 opacity-50">Methodology and Data Sources</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#definition-of-annual-prevalence" class="transition-opacity hover:opacity-100 opacity-50">Definition of Annual Prevalence</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#primary-global-sources" class="transition-opacity hover:opacity-100 opacity-50">Primary Global Sources</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#survey-techniques-and-comparability-issues" class="transition-opacity hover:opacity-100 opacity-50">Survey Techniques and Comparability Issues</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#global-and-regional-patterns" class="transition-opacity hover:opacity-100 opacity-50">Global and Regional Patterns</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#worldwide-prevalence-overview" class="transition-opacity hover:opacity-100 opacity-50">Worldwide Prevalence Overview</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#regional-variations-in-use-rates" class="transition-opacity hover:opacity-100 opacity-50">Regional Variations in Use Rates</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#country-specific-rankings" class="transition-opacity hover:opacity-100 opacity-50">Country-Specific Rankings</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#countries-with-highest-reported-use" class="transition-opacity hover:opacity-100 opacity-50">Countries with Highest Reported Use</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#countries-with-lowest-reported-use" class="transition-opacity hover:opacity-100 opacity-50">Countries with Lowest Reported Use</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#key-national-trends-and-changes" class="transition-opacity hover:opacity-100 opacity-50">Key National Trends and Changes</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#factors-influencing-prevalence" class="transition-opacity hover:opacity-100 opacity-50">Factors Influencing Prevalence</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#legal-policy-effects-on-use-rates" class="transition-opacity hover:opacity-100 opacity-50">Legal Policy Effects on Use Rates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cultural-economic-and-demographic-drivers" class="transition-opacity hover:opacity-100 opacity-50">Cultural, Economic, and Demographic Drivers</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#data-limitations-and-debates" class="transition-opacity hover:opacity-100 opacity-50">Data Limitations and Debates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#sources-of-underreporting-and-bias" class="transition-opacity hover:opacity-100 opacity-50">Sources of Underreporting and Bias</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#implications-for-policy-and-interpretation" class="transition-opacity hover:opacity-100 opacity-50">Implications for Policy and Interpretation</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="list-of-countries-by-annual-cannabis-use" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">List of countries by annual cannabis use<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">
The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological variances and reporting biases persist across datasets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Cannabis constitutes the most commonly used controlled substance globally, with approximately 244 million past-year users in 2023, corresponding to 4.6 percent of the world&#x27;s 15–64 population, marking a rise from 3.9 percent a decade prior.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Prevalence disparities are stark, peaking in regions like North America, Oceania, and West and Central Africa—where rates often exceed 10 percent—while remaining negligible under 1 percent in much of Asia and the Middle East, reflecting influences such as prohibitive legal regimes, cultural prohibitions, and enforcement stringency that likely suppress honest disclosure in surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Shifts toward liberalization in select jurisdictions, including full recreational legalization in Canada, Uruguay, and various U.S. states, correlate with elevated reported usage, attributable to diminished barriers to access and reduced social stigma rather than inherent demand alterations. Empirical challenges in compiling such lists include inconsistent survey frequencies, non-response biases, and the UNODC&#x27;s reliance on member-state submissions, which may understate true incidence in authoritarian contexts with harsh penalties.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<h2 id="methodology-and-data-sources" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Methodology and Data Sources<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="definition-of-annual-prevalence" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Definition of Annual Prevalence<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Annual prevalence of cannabis use measures the percentage of a specified population that reports having consumed cannabis at least once during the preceding 12 months.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> This indicator, often termed &quot;past-year prevalence,&quot; is derived primarily from general population surveys targeting individuals aged 15 to 64 years, as this age range captures the majority of non-medical drug consumption patterns while excluding most underage and elderly respondents unlikely to participate in household-based sampling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Such surveys typically employ self-reported data collected through structured questionnaires administered in person, by telephone, or online, with efforts to ensure anonymity to minimize underreporting.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_62abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The metric serves as a standardized compromise between lifetime prevalence—which indicates ever-use and may inflate estimates by including distant or one-time exposures—and past-30-day (current) prevalence, which focuses on recent activity but excludes occasional users active within the year.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> For cannabis, annual prevalence is particularly useful for cross-national comparisons, as it reflects recent exposure without capturing chronic dependence or daily habits, which are better assessed via intensity measures like frequency of use or treatment demand indicators.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Global estimates, such as those from the United Nations Office on Drugs and Crime (UNODC), apply this definition consistently across regions, adjusting for survey methodology differences where possible, though variations in question wording (e.g., &quot;used cannabis&quot; versus &quot;used marijuana or hashish&quot;) can introduce minor discrepancies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_62qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In practice, annual prevalence rates for cannabis hover around 3-4% globally among the 15-64 population, but they are sensitive to cultural attitudes toward reporting, legalization status, and sampling biases favoring urban or accessible households.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_23abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Organizations like the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) align with this definition for European data, emphasizing its role in tracking trends over time rather than absolute incidence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Limitations include potential underestimation due to stigma in prohibitive jurisdictions or overestimation from recall bias, underscoring the need for triangulation with indirect indicators like seizures or wastewater analysis in comprehensive assessments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_63abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<h3 id="primary-global-sources" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Primary Global Sources<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The United Nations Office on Drugs and Crime (UNODC) serves as the principal global authority for compiling and disseminating data on cannabis use prevalence, drawing from national household surveys, treatment records, and seizure data across member states. Its annual <em>World Drug Report</em>, with the 2025 edition released on June 26, 2025, estimates that 228 million people aged 15–64 used cannabis at least once in the preceding year as of 2023 data, representing approximately 4.7% of the global population in that age group. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> These figures aggregate country-level estimates where available, though coverage varies due to inconsistent reporting from low- and middle-income nations, with prevalence rates derived via statistical modeling for gaps.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_64abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The World Health Organization (WHO) supplements UNODC data through periodic global health surveys, such as the World Health Survey and mental health atlases, which include self-reported cannabis use metrics from participating countries. For instance, WHO data from 2016–2022 indicate annual prevalence rates ranging from under 1% in parts of Asia to over 10% in regions like Oceania and North America, though these are less frequently updated than UNODC reports and often rely on smaller sample sizes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> WHO&#x27;s estimates prioritize health impacts but face criticism for under-sampling high-use populations due to reliance on voluntary national contributions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regional bodies like the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) provide detailed data for Europe, reporting 8.4% annual prevalence among adults aged 15–64 in 2023 based on harmonized surveys, which UNODC incorporates into global aggregates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Similarly, the Inter-American Drug Abuse Control Commission (CICAD) compiles Americas-specific figures, but these feed into UNODC&#x27;s framework rather than standing as independent global sources. Overall, UNODC&#x27;s methodology emphasizes empirical triangulation to mitigate biases in self-reported data, such as underreporting in prohibitive legal environments, though absolute country rankings remain approximate due to survey non-comparability.</span>
<h3 id="survey-techniques-and-comparability-issues" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Survey Techniques and Comparability Issues<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Surveys measuring annual cannabis use prevalence primarily rely on self-reported data from nationally representative household surveys targeting the general population aged 15-64, which are considered reliable for estimating cannabis, amphetamine-type stimulants, and cocaine use due to respondents&#x27; willingness to disclose such behaviors compared to harder drugs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_26abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> School-based surveys, such as the European School Survey Project on Alcohol and Other Drugs (ESPAD) or equivalents like the U.S. Monitoring the Future, capture data among 15- to 16-year-olds, with adjustments applied using regional benchmarks from countries like the United States, Colombia, and Pakistan to derive broader estimates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Data aggregation occurs through mechanisms like the United Nations Office on Drugs and Crime (UNODC) Annual Report Questionnaire (ARQ), which compiles national survey results from member states, supplemented by regional bodies such as the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for Europe.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_66abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Annual prevalence is often derived indirectly from lifetime use data via regional conversion ratios—for instance, a ratio of 0.387 in West and Central Europe—due to inconsistencies in direct reporting across surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_26qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Extrapolation techniques, including regression models or treatment-to-user multipliers, fill gaps where primary surveys are absent, particularly in low-response regions like Africa (57% ARQ participation) or Oceania (12.5%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Comparability across countries is hindered by variations in survey design, including sampling frames that may exclude transient populations like the homeless or incarcerated, leading to underestimation in urban-heavy samples.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_27abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Underreporting is prevalent due to social desirability bias, exacerbated in jurisdictions with strict prohibitions, where fear of legal repercussions suppresses disclosure, whereas legalized settings like parts of Canada or Uruguay yield higher reported rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> Differences in question wording—such as defining &quot;use&quot; as any consumption versus repeated instances—and recall accuracy for the past-year period introduce further inconsistencies, with validity of estimates varying by national context and potentially biasing cross-country comparisons.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_67abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Temporal mismatches arise from outdated data or disruptions like the COVID-19 pandemic, which halted surveys in 2020-2021 and affected response rates, while small nations (population under 100,000 aged 15-64) are often excluded from extrapolations to avoid distortion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_27qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Heterogeneity in age standardization, response definitions (e.g., chronic versus occasional use), and reliance on indirect methods like wastewater analysis or seizure multipliers compounds uncertainty, with UNODC applying 10th-90th percentile ranges to quantify variability but noting persistent gaps in over 60 countries lacking recent household surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<h2 id="global-and-regional-patterns" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Global and Regional Patterns<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="worldwide-prevalence-overview" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Worldwide Prevalence Overview<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">In 2023, an estimated 244 million people aged 15-64, or 4.6% of the global population in that age group, reported past-year cannabis use, making it the most prevalent illicit drug worldwide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> This figure represents a one-third increase from the 3.9% prevalence recorded a decade earlier in 2013, reflecting rising consumption patterns amid expanding production and market diversification.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Prevalence varies significantly by gender, with 7.0% of men and 2.3% of women reporting use in the past year.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_69qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regional disparities underscore the global overview, with North America exhibiting the highest rates, followed by Oceania (Australia and New Zealand) and parts of West and Central Africa.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Among adolescents aged 15-16, past-year use stood at 4.4% globally in 2023, comparable to adult rates but carrying heightened risks of cognitive and mental health impacts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> These estimates, derived from surveys across 135 countries covering 70% of the world&#x27;s population, highlight cannabis&#x27;s dominance in treatment-seeking for drug use disorders, accounting for 42% of reporting countries&#x27; primary substance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> However, underreporting remains a challenge in regions with strict prohibitions, potentially understating true prevalence in data-scarce areas like much of Asia and the Middle East.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h3 id="regional-variations-in-use-rates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Regional Variations in Use Rates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Annual prevalence of cannabis use among adults aged 15-64 varies markedly across regions, with North America and Oceania exhibiting the highest rates globally. In North America, prevalence stands at approximately 20.2 percent, driven primarily by high use in the United States and Canada where legalization has coincided with increased accessibility.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Oceania follows closely, with rates around 12 percent overall, reflecting elevated use in Australia and New Zealand, where past-year prevalence exceeds 10 percent in national surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Europe demonstrates moderate prevalence, averaging about 8 percent, though with subregional differences: Western and Central Europe report higher rates near 10 percent for men, while Eastern Europe tends lower.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> In contrast, Asia records the lowest regional rates at roughly 1.5 percent, with male prevalence at 2.7 percent and female at 0.3 percent, attributed to strict prohibitions and cultural stigmas in many countries.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Africa shows heterogeneous patterns, with West and Central subregions displaying higher prevalence—men at 10.9 percent—potentially linked to local production and traditional uses, while overall continental estimates hover around 6 percent.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> South America averages 4.1 percent, lower than North America but with variations such as higher rates in Uruguay post-legalization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These disparities underscore the influence of policy, enforcement, and socioeconomic factors on use patterns, though data comparability remains challenged by survey methodologies and underreporting in prohibitive contexts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>








































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Region</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Approximate Annual Prevalence (15-64, %)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Key Notes</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">North America</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20.2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Highest globally; legalization impact</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Oceania</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~12</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">High in Australia/New Zealand</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Europe</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~8</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Moderate, higher in West</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Africa</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~6</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Elevated in West/Central subregions</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Asia</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~1.5</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Lowest; strict controls</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">South America</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">4.1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Variable post-policy changes</span></td></tr></tbody></table></div>
<h2 id="country-specific-rankings" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Country-Specific Rankings<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="countries-with-highest-reported-use" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Countries with Highest Reported Use<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The countries with the highest reported annual cannabis use, based on general population surveys, are predominantly those with permissive cultural attitudes or legal frameworks, where self-reporting is less stigmatized. A 2024 systematic review and meta-analysis of studies from 2000 to 2024 identified peak rates exceeding 40% in select cases, though such figures derive from national household or population-based surveys prone to methodological variations, including differences in age groups sampled (typically 15-64 years) and question phrasing on past-year use. These outliers contrast with UNODC global estimates of around 4% annual prevalence, highlighting potential over-reporting in low-stigma environments versus under-reporting elsewhere due to legal risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Reported highs cluster in Oceania, Western Europe, and North America. For instance, Australia recorded 48.70% past-year use in a 2004 national survey, reflecting broad accessibility and cultural normalization prior to subsequent declines amid policy shifts. The Netherlands followed with 43.90% in 2013, aligned with de facto tolerance in coffee shops, though subsequent European Monitoring Centre for Drugs and Drug Addiction data suggest stabilization around 10-15% in recent years due to tighter regulations. In North America, the United States reported 38.12% in 2021 National Survey on Drug Use and Health data for the population aged 12 and older, driven by state-level legalization expanding access, with daily use rising post-reform.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>









































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Reported Annual Prevalence</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Year</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Source Notes</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Australia</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">48.70%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2004</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">National household survey; high due to low stigma</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k6gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Netherlands</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">43.90%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2013</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">General population survey; tolerance policy context</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kagabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">United States</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">38.12%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2021</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">NSDUH, ages 12+; legalization effects</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kegabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Spain</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">25.72%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Regional variations; club-based access</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kigabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Brazil</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">23.10%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2019</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Urban-focused survey; rising trend</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kmgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Comparability remains challenged by survey timing and enforcement climates; for example, African nations like Nigeria report 19.4% (2019), potentially undercounted due to severe penalties, while UNODC regional modeling adjusts West Africa to around 9-10% overall. In Canada, post-2018 legalization surveys indicate 25-30% adult past-year use by 2023, exceeding pre-reform levels but below unadjusted self-reports in earlier liberal benchmarks. These patterns underscore causal links between reduced enforcement and elevated disclosure, rather than necessarily higher absolute consumption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<h3 id="countries-with-lowest-reported-use" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Countries with Lowest Reported Use<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Several nations in the Middle East and East Asia report annual cannabis use prevalence rates below 0.5% among adults aged 15-64, reflecting rigorous enforcement of prohibition laws, religious and cultural norms against intoxication, and societal pressures that discourage disclosure in surveys. Qatar records the lowest documented rate at 0.1%, followed by Saudi Arabia at 0.3%, based on aggregated national and regional data compilations. These figures likely underestimate true usage due to fear of legal repercussions—punishments in Saudi Arabia include flogging, imprisonment, or execution for drug offenses—leading to systematic underreporting in self-reported surveys, a common issue in authoritarian or theocratic regimes where data collection relies on voluntary admission rather than objective measures like wastewater analysis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In East Asia, China, Japan, South Korea, Hong Kong, Vietnam, and Taiwan all report past-year prevalence under 0.5%, with China&#x27;s total registered drug users (across all substances) numbering only 1.12 million in a population exceeding 1.4 billion as of 2022, implying cannabis-specific rates near negligible levels. Japan&#x27;s illicit drug use remains low overall, with cannabis as the most prevalent but still affecting fewer than 1% annually, per government-monitored trends up to 2017 that show gradual increases yet retention of minimal baseline rates. These low reports align with zero-tolerance policies, such as Japan&#x27;s three-year minimum sentence for possession and China&#x27;s execution risks for trafficking, which prioritize deterrence over harm reduction and correlate with suppressed visibility of use. Peer-reviewed analyses confirm Asia&#x27;s regional average at approximately 2%, far below global norms, though cross-national comparability is limited by varying survey methodologies and non-response biases in conservative societies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Other examples include Malaysia, identified in comparative studies as having among the lowest prevalence and dependence rates in Southeast Asia, and Brunei, where Sharia-based prohibitions yield near-absent reported use amid capital penalties for trafficking. In the Islamic Republic of Afghanistan under Taliban rule since 2021, cultivation persists for export but domestic consumption is severely curtailed by public executions and destruction campaigns, resulting in de facto near-zero reported annual use despite historical highs pre-2021. Such patterns underscore causal links between draconian enforcement and visible restraint, though empirical evidence from indirect indicators like seizures suggests hidden consumption persists at low levels; for instance, UNODC data highlights Asia&#x27;s overall cannabis user estimate at 54 million (2% prevalence) versus higher regional averages elsewhere. Credible sources like UNODC emphasize that these minima are not necessarily indicative of absolute rarity but of effective suppression of open use, with academic biases toward liberalization potentially downplaying enforcement efficacy in interpretations of the data.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<h3 id="key-national-trends-and-changes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Key National Trends and Changes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In Canada, recreational cannabis legalization in October 2018 correlated with an initial rise in annual prevalence, with past-year use among those aged 15 and older increasing from 15% in 2018 to 22% by 2021, driven partly by reduced perceived risks and expanded access.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> Subsequent national monitoring through 2024 shows stabilization in past-year rates alongside a modest uptick in past-30-day use to 17%, though daily or near-daily consumption edged higher from 7% pre-legalization to 8% post-legalization among workers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> These shifts reflect broader normalization, with heavier use patterns persisting among young adults aged 20-24, where prevalence exceeds 50% in some cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the United States, the National Survey on Drug Use and Health (NSDUH) documents a substantial long-term increase in past-year cannabis use, rising from 11% in 2002 to 25% in 2022 among individuals aged 12 and older, with per capita rates doubling since 2008 amid progressive state-level decriminalization and commercialization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Frequent use (daily or near-daily) among adults also climbed from 1.9% in 2002 to 3.5% by 2014, a trajectory that continued into the 2020s despite federal restrictions, as past-year prevalence reached 19% overall by 2023 estimates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> Youth trends show volatility, with past-year use among adolescents increasing from 7.6% in 2013 to 15.1% in 2022 before plateauing.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Across Europe, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reports steady growth in cannabis prevalence, with last-year use estimated at 8.4% among adults aged 15-64 in recent national surveys, and past-month use up 27% from 2010 to 2019 levels at 3.9%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Among young adults aged 15-34, last-year prevalence hovered at 15.1% as of 2023, with males twice as likely to report use, though country variations persist—higher in nations like Spain and France, lower in Eastern Europe.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> These increments align with rising potency and market availability, despite uneven policy reforms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Globally, United Nations Office on Drugs and Crime (UNODC) data indicate cannabis remains the most prevalent illicit substance, with 219 million past-year users (4.3% of adults) in 2021, up from prior estimates, though 44% of reporting countries noted stable rates between surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> Increases predominate in legalized or tolerant jurisdictions, while prohibitionist regions like parts of Asia and the Middle East sustain low prevalence below 1%, with minimal documented shifts due to enforcement and cultural stigma.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<h2 id="factors-influencing-prevalence" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Factors Influencing Prevalence<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="legal-policy-effects-on-use-rates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Legal Policy Effects on Use Rates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Empirical studies on jurisdictions transitioning from prohibition or decriminalization to regulated recreational cannabis markets indicate that legal policy changes have generally resulted in modest or negligible shifts in overall annual prevalence rates, with variations by age group and timeframe. In the United States, where 24 states had legalized recreational use by 2023, meta-analyses of state-level data from 2012 onward show small increases in past-month adult use (approximately 1-2 percentage points) following implementation, but no consistent rise in youth prevalence; for instance, Monitoring the Future surveys reported stable or declining adolescent use rates post-legalization in states like Colorado and Washington.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> These findings suggest that pre-existing upward trends in use, driven by shifting attitudes, accounted for much of the observed change rather than policy alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Canada&#x27;s national legalization in October 2018 provides a controlled national case, where past-year cannabis use among adults aged 15 and older rose slightly from 15% in 2018 to 17% by 2024, aligning with a 2-3% increase in past-30-day use, though rates stabilized after 2020 and remained below peaks in some subgroups.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> Longitudinal data indicate this increment continued a pre-legalization trajectory of rising use from 2013-2017, with no evidence of exponential growth; youth use (ages 15-24) showed minimal change, hovering around 20-25% past-year prevalence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup> In Uruguay, the world&#x27;s first nation to fully legalize recreational cannabis in 2013, annual prevalence remained stable at 7-9% through 2022, with problematic use fixed at 2.1% since 2011 and overall consumption declining from 14.6% in 2018 to 12.3% by 2024 among surveyed populations, attributed partly to regulated supply reducing unregulated access.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Decriminalization without full commercialization, as in Portugal since 2001, correlates with sustained low prevalence; lifetime cannabis use among adults fell from 7.8% in 2001 to 5.9% by 2019, alongside reduced treatment admissions, challenging assumptions that laxer policies inherently drive uptake.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> Conversely, stringent prohibition in countries like Singapore yields reported annual rates below 1%, but surveys likely undercount due to severe penalties (up to 10 years imprisonment for possession), illustrating enforcement&#x27;s role in suppressing visibility rather than eliminating demand.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> Systematic reviews emphasize that policy effects are heterogeneous, with modest positive associations for young adult initiation (odds ratio ~1.1-1.3) but limited causal impact on heavy use, as access barriers under prohibition fail to deter determined users while fostering black markets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></span>








































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Jurisdiction</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Policy Change</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Pre-Change Annual Prevalence (%)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Post-Change Annual Prevalence (%)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Key Notes</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Canada (National)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Recreational legalization (2018)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">15 (2018)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">17 (2024, adults 15+)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Slight rise, trend continuation; youth stable.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l6oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Uruguay (National)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Recreational legalization (2013)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~8 (2011)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~8 (2022)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Stable overall; problematic use unchanged.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_laoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorado, USA (State)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Recreational legalization (2012)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">12.3 (2011, past-year adults)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">13.6 (2015)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Modest adult increase; youth no change.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_leoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Portugal (National)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Decriminalization (2001)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">7.8 lifetime (2001)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5.9 lifetime (2019)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Decrease post-policy; low enforcement focus.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lioabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">These patterns underscore that legal policies influence reported access and normalization more than underlying demand, with no jurisdiction exhibiting the dramatic surges predicted by deterrence models; instead, prevalence aligns closely with cultural and socioeconomic drivers. Peer-reviewed evidence tempers claims from advocacy sources overstating either harms or benefits, highlighting the need for longitudinal controls to isolate policy from secular trends.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<h3 id="cultural-economic-and-demographic-drivers" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cultural, Economic, and Demographic Drivers<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cultural attitudes toward cannabis, shaped by religious doctrines and historical traditions, exert substantial influence on national prevalence rates. In predominantly Islamic countries, where religious texts interpret cannabis as an intoxicant prohibited under Sharia law, annual use remains minimal, often below 1% in nations like Saudi Arabia and Iran, as doctrinal enforcement suppresses both production and consumption. Conversely, in Hindu-majority India, cannabis derivatives such as bhang hold sacramental roles in rituals associated with Shiva worship, contributing to a cultural tolerance that sustains moderate prevalence around 3% among adults, though recreational use is less widespread than in Western contexts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> These patterns underscore how entrenched cultural norms, independent of legal status, can either entrench stigma or foster acceptance, with secular Western societies exhibiting higher rates due to diminished religious opposition to psychoactive substances.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Economic factors, particularly national wealth, correlate positively with cannabis use in cross-national analyses of youth. A study across 31 European and North American countries identified higher GDP per capita as associated with increased frequent use among mid-adolescents, attributing this to greater disposable income facilitating access and social experimentation in affluent settings. However, this trend contrasts with intra-country data from the United States, where lower-income groups report higher usage rates, suggesting that at the global level, prosperity enables recreational rather than coping-driven consumption, while poverty in developing regions may amplify use through informal markets despite lower overall reporting. African nations like Nigeria, with 19.4% prevalence despite modest GDP, illustrate how economic informality and agricultural production can sustain high rates amid underinvestment in alternatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Demographic variables, including gender, age structure, and urbanization, systematically shape prevalence disparities. Globally, males exhibit nearly three times the annual use rate of females, as documented in UNODC estimates, reflecting biological, social, and risk-taking differences amplified across cultures. Youth-dominated populations drive higher national figures, with peak use in the 15-34 age cohort, as older groups show sharp declines; countries with bulging youth demographics, such as those in sub-Saharan Africa, thus report elevated averages despite data inconsistencies. Urbanization further elevates rates, with urban dwellers facing heightened exposure through dense social networks and availability, as evidenced in European contexts where city prevalence exceeds rural by factors of 1.5-2, a pattern linked to migration and lifestyle shifts rather than policy alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></span>
<h2 id="data-limitations-and-debates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Data Limitations and Debates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="sources-of-underreporting-and-bias" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Sources of Underreporting and Bias<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Self-reported surveys, which form the basis of most international cannabis prevalence estimates, systematically underestimate actual use due to respondents&#x27; reluctance to disclose illicit behavior. Validation studies using biological markers such as hair assays reveal that self-reports underreport substance use prevalence by 30% to 60%, with an average detection ratio of 1.50 when compared to objective tests.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup> For cannabis specifically, discrepancies arise when users report alternative forms like blunts without acknowledging cannabis content, leading to adjusted past-year prevalence estimates rising from reported figures to 15.5% in some national samples.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Legal status exacerbates underreporting in countries where cannabis remains prohibited, as fear of legal consequences prompts non-disclosure or survey non-response. In jurisdictions with harsh penalties, respondents anticipate prosecution risks, even in anonymous surveys, resulting in lower reported rates compared to legalized regions where disclosure barriers diminish.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> Criminalization frameworks amplify this effect by fostering perceptions of use as inherently deviant, correlating with diminished self-reporting across global datasets compiled by bodies like the UNODC.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cultural stigma compounds these issues, particularly in conservative or collectivist societies where admitting drug use invites social ostracism or familial repercussions, independent of legal risks. Stigma-driven underreporting manifests in reduced treatment-seeking and survey participation, with international comparisons showing higher discrepancies in regions prioritizing moralistic views over harm reduction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup> Methodological biases further distort data; for instance, interview mode influences candor, with telephone surveys yielding higher underreporting among certain demographics due to perceived lower anonymity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">International statistics exhibit regional biases, with more reliable data from Western Europe and North America—where EMCDDA and similar agencies employ standardized, anonymous protocols—contrasting sparse or manipulated reports from authoritarian states or low-resource areas. In policy-restrictive environments, governments may suppress or fabricate low-use figures to align with anti-drug narratives, while post-legalization shifts in perception reduce stigma but introduce overreporting risks from normalized attitudes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> These asymmetries privilege empirical data from high-credibility sources like peer-reviewed validations over unverified national claims, highlighting the need for biomarker corroboration in global rankings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<h3 id="implications-for-policy-and-interpretation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Implications for Policy and Interpretation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Data on annual cannabis prevalence reveal that countries enforcing strict prohibition, such as those in the Middle East and parts of Asia, consistently report rates below 1%, suggesting effective deterrence through severe penalties and cultural stigma when enforcement is rigorous.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> In contrast, nations with legalization or decriminalization, including Canada and Uruguay, have observed post-reform increases in adult use, with Canada&#x27;s past-year prevalence rising from approximately 15% pre-2018 to over 20% by 2021, alongside accelerated daily use patterns.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup> These trends imply that policy liberalization correlates with normalized consumption among adults, potentially eroding perceptions of harm, as evidenced by declining risk assessments in legalized U.S. states.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Policy formulation must account for causal factors beyond legality, including enforcement capacity and sociocultural norms; empirical evidence indicates prohibition suppresses prevalence more reliably in homogeneous societies with low tolerance for intoxicants, whereas Western contexts show modest use upticks post-legalization without corresponding youth surges.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup> Decriminalization models, like Portugal&#x27;s, have not demonstrably reduced cannabis-specific prevalence compared to stricter regimes, highlighting that supply regulation may mitigate black-market harms but invites higher potency products and treatment demands.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> Thus, blanket legalization risks amplifying public health burdens, such as increased healthcare utilization, absent targeted interventions like age restrictions and education.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_avabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Interpreting rankings requires caution due to methodological variances; self-reported surveys in prohibitive jurisdictions likely understate true use owing to stigma-induced non-disclosure, while liberal environments yield more candid data, potentially inflating comparative prevalence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> Cross-national analyses must disentangle policy effects from confounders like economic prosperity and youth demographics, as higher-use nations often feature urbanized, affluent populations predisposed to experimentation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup> Policymakers interpreting these disparities should prioritize evidence of enforcement efficacy over ideological shifts toward permissiveness, recognizing that sustained low prevalence under prohibition underscores viable alternatives to commodification.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf</a></span></div></li><li id="https://dataunodc.un.org/dp-drug-use-prevalence" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/dp-drug-use-prevalence" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/dp-drug-use-prevalence</a></span></div></li><li id="https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8589728/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8589728/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8589728/</a></span></div></li><li id="https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html</a></span></div></li><li id="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html</a></span></div></li><li id="https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis</a></span></div></li><li id="https://www.euda.europa.eu/publications/european-drug-report/2025/cannabis_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/european-drug-report/2025/cannabis_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/european-drug-report/2025/cannabis_en</a></span></div></li><li id="https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0955395912000758" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0955395912000758" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0955395912000758</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2666776221002131" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2666776221002131" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2666776221002131</a></span></div></li><li id="https://www.euda.europa.eu/publications/european-drug-report/2025_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/european-drug-report/2025_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/european-drug-report/2025_en</a></span></div></li><li id="https://worldpopulationreview.com/country-rankings/cannabis-use-by-country" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://worldpopulationreview.com/country-rankings/cannabis-use-by-country" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://worldpopulationreview.com/country-rankings/cannabis-use-by-country</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/32009041/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/32009041/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/32009041/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/</a></span></div></li><li id="https://www150.statcan.gc.ca/n1/daily-quotidien/231016/dq231016c-eng.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www150.statcan.gc.ca/n1/daily-quotidien/231016/dq231016c-eng.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www150.statcan.gc.ca/n1/daily-quotidien/231016/dq231016c-eng.htm</a></span></div></li><li id="https://health-infobase.canada.ca/cannabis/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://health-infobase.canada.ca/cannabis/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://health-infobase.canada.ca/cannabis/</a></span></div></li><li id="https://www.iwh.on.ca/plain-language-summaries/cannabis-use-by-workers-before-and-after-legalization-in-canada" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.iwh.on.ca/plain-language-summaries/cannabis-use-by-workers-before-and-after-legalization-in-canada" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.iwh.on.ca/plain-language-summaries/cannabis-use-by-workers-before-and-after-legalization-in-canada</a></span></div></li><li id="https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-024-01112-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-024-01112-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-024-01112-9</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK609482/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK609482/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK609482/</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1111/add.16519" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1111/add.16519" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1111/add.16519</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8905582/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8905582/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8905582/</a></span></div></li><li id="https://www.cdc.gov/cannabis/data-research/facts-stats/index.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/cannabis/data-research/facts-stats/index.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/cannabis/data-research/facts-stats/index.html</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2772724624000374" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2772724624000374" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2772724624000374</a></span></div></li><li id="https://www.euda.europa.eu/publications/european-drug-report/2023/cannabis_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/european-drug-report/2023/cannabis_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/european-drug-report/2023/cannabis_en</a></span></div></li><li id="https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762%2821%2900213-1/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762%2821%2900213-1/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762%2821%2900213-1/fulltext</a></span></div></li><li id="https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf</a></span></div></li><li id="https://docs.un.org/en/E/CN.7/2023/CRP.18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://docs.un.org/en/E/CN.7/2023/CRP.18" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://docs.un.org/en/E/CN.7/2023/CRP.18</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/38552901/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/38552901/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/38552901/</a></span></div></li><li id="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8253-4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8253-4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8253-4</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0955395924000707" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0955395924000707" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0955395924000707</a></span></div></li><li id="https://internationalcbc.com/did-cannabis-usage-rates-spike-in-uruguay-and-canada-post-legalization/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://internationalcbc.com/did-cannabis-usage-rates-spike-in-uruguay-and-canada-post-legalization/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://internationalcbc.com/did-cannabis-usage-rates-spike-in-uruguay-and-canada-post-legalization/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0955395925000957" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0955395925000957" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0955395925000957</a></span></div></li><li id="https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2024.116" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2024.116" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2024.116</a></span></div></li><li id="https://bmjopen.bmj.com/content/9/7/e025880" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmjopen.bmj.com/content/9/7/e025880" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmjopen.bmj.com/content/9/7/e025880</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10036775/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10036775/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10036775/</a></span></div></li><li id="https://www.nber.org/system/files/working_papers/w28647/w28647.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nber.org/system/files/working_papers/w28647/w28647.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nber.org/system/files/working_papers/w28647/w28647.pdf</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6153265/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6153265/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6153265/</a></span></div></li><li id="https://link.springer.com/article/10.1007/s40429-023-00500-8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s40429-023-00500-8" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s40429-023-00500-8</a></span></div></li><li id="https://www.researchgate.net/publication/7327496_Economic_and_cultural_correlates_of_cannabis_use_among_mid-adolescents_in_31_countries" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/7327496_Economic_and_cultural_correlates_of_cannabis_use_among_mid-adolescents_in_31_countries" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/7327496_Economic_and_cultural_correlates_of_cannabis_use_among_mid-adolescents_in_31_countries</a></span></div></li><li id="https://econtent.hogrefe.com/doi/10.1024//1421-0185.60.2.99" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://econtent.hogrefe.com/doi/10.1024//1421-0185.60.2.99" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://econtent.hogrefe.com/doi/10.1024//1421-0185.60.2.99</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S089085672300045X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S089085672300045X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S089085672300045X</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8720324/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8720324/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8720324/</a></span></div></li><li id="https://journals.sagepub.com/doi/abs/10.1080/08897077.2021.1941520" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.sagepub.com/doi/abs/10.1080/08897077.2021.1941520" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.sagepub.com/doi/abs/10.1080/08897077.2021.1941520</a></span></div></li><li id="https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf</a></span></div></li><li id="https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-020-00288-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-020-00288-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-020-00288-0</a></span></div></li><li id="https://www.researchgate.net/publication/249278027_Diminished_Lifetime_Substance_Use_Over_Time_An_Inquiry_Into_Differential_Underreporting" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/249278027_Diminished_Lifetime_Substance_Use_Over_Time_An_Inquiry_Into_Differential_Underreporting" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/249278027_Diminished_Lifetime_Substance_Use_Over_Time_An_Inquiry_Into_Differential_Underreporting</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4897110/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4897110/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4897110/</a></span></div></li><li id="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html</a></span></div></li><li id="https://www.unodc.org/unodc/frontpage/2022/June/unodc-world-drug-report-2022-highlights-trends-on-cannabis-post-legalization--environmental-impacts-of-illicit-drugs--and-drug-use-among-women-and-youth.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/frontpage/2022/June/unodc-world-drug-report-2022-highlights-trends-on-cannabis-post-legalization--environmental-impacts-of-illicit-drugs--and-drug-use-among-women-and-youth.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/frontpage/2022/June/unodc-world-drug-report-2022-highlights-trends-on-cannabis-post-legalization--environmental-impacts-of-illicit-drugs--and-drug-use-among-women-and-youth.html</a></span></div></li><li id="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15883-6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15883-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15883-6</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2468266724002998" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2468266724002998" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2468266724002998</a></span></div></li><li id="https://www.ccjm.org/content/92/7/407" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ccjm.org/content/92/7/407" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ccjm.org/content/92/7/407</a></span></div></li><li id="https://www.healthaffairs.org/do/10.1377/hpb20210701.500845/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthaffairs.org/do/10.1377/hpb20210701.500845/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthaffairs.org/do/10.1377/hpb20210701.500845/</a></span></div></li><li id="https://www.tni.org/files/publication-downloads/icsdp-cannabis_report.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tni.org/files/publication-downloads/icsdp-cannabis_report.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tni.org/files/publication-downloads/icsdp-cannabis_report.pdf</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0" id="_R_" async=""></script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"List_of_countries_by_annual_cannabis_use\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"List_of_countries_by_annual_cannabis_use\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"List_of_countries_by_annual_cannabis_use\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:Ta61c,"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"# List of countries by annual cannabis use\n\n![World map of countries by annual prevalence of cannabis use](./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png)\nThe list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological variances and reporting biases persist across datasets.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html) Cannabis constitutes the most commonly used controlled substance globally, with approximately 244 million past-year users in 2023, corresponding to 4.6 percent of the world's 15–64 population, marking a rise from 3.9 percent a decade prior.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) Prevalence disparities are stark, peaking in regions like North America, Oceania, and West and Central Africa—where rates often exceed 10 percent—while remaining negligible under 1 percent in much of Asia and the Middle East, reflecting influences such as prohibitive legal regimes, cultural prohibitions, and enforcement stringency that likely suppress honest disclosure in surveys.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/) Shifts toward liberalization in select jurisdictions, including full recreational legalization in Canada, Uruguay, and various U.S. states, correlate with elevated reported usage, attributable to diminished barriers to access and reduced social stigma rather than inherent demand alterations. Empirical challenges in compiling such lists include inconsistent survey frequencies, non-response biases, and the UNODC's reliance on member-state submissions, which may understate true incidence in authoritarian contexts with harsh penalties.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html)\n\n## Methodology and Data Sources\n\n### Definition of Annual Prevalence\n\nAnnual prevalence of cannabis use measures the percentage of a specified population that reports having consumed cannabis at least once during the preceding 12 months.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf) This indicator, often termed \"past-year prevalence,\" is derived primarily from general population surveys targeting individuals aged 15 to 64 years, as this age range captures the majority of non-medical drug consumption patterns while excluding most underage and elderly respondents unlikely to participate in household-based sampling.[](https://dataunodc.un.org/dp-drug-use-prevalence) Such surveys typically employ self-reported data collected through structured questionnaires administered in person, by telephone, or online, with efforts to ensure anonymity to minimize underreporting.[](https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf)\n\nThe metric serves as a standardized compromise between lifetime prevalence—which indicates ever-use and may inflate estimates by including distant or one-time exposures—and past-30-day (current) prevalence, which focuses on recent activity but excludes occasional users active within the year.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf) For cannabis, annual prevalence is particularly useful for cross-national comparisons, as it reflects recent exposure without capturing chronic dependence or daily habits, which are better assessed via intensity measures like frequency of use or treatment demand indicators.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8589728/) Global estimates, such as those from the United Nations Office on Drugs and Crime (UNODC), apply this definition consistently across regions, adjusting for survey methodology differences where possible, though variations in question wording (e.g., \"used cannabis\" versus \"used marijuana or hashish\") can introduce minor discrepancies.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf)\n\nIn practice, annual prevalence rates for cannabis hover around 3-4% globally among the 15-64 population, but they are sensitive to cultural attitudes toward reporting, legalization status, and sampling biases favoring urban or accessible households.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) Organizations like the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) align with this definition for European data, emphasizing its role in tracking trends over time rather than absolute incidence.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8589728/) Limitations include potential underestimation due to stigma in prohibitive jurisdictions or overestimation from recall bias, underscoring the need for triangulation with indirect indicators like seizures or wastewater analysis in comprehensive assessments.[](https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf)\n\n### Primary Global Sources\n\nThe United Nations Office on Drugs and Crime (UNODC) serves as the principal global authority for compiling and disseminating data on cannabis use prevalence, drawing from national household surveys, treatment records, and seizure data across member states. Its annual *World Drug Report*, with the 2025 edition released on June 26, 2025, estimates that 228 million people aged 15–64 used cannabis at least once in the preceding year as of 2023 data, representing approximately 4.7% of the global population in that age group. [](https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html) These figures aggregate country-level estimates where available, though coverage varies due to inconsistent reporting from low- and middle-income nations, with prevalence rates derived via statistical modeling for gaps.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html)\n\nThe World Health Organization (WHO) supplements UNODC data through periodic global health surveys, such as the World Health Survey and mental health atlases, which include self-reported cannabis use metrics from participating countries. For instance, WHO data from 2016–2022 indicate annual prevalence rates ranging from under 1% in parts of Asia to over 10% in regions like Oceania and North America, though these are less frequently updated than UNODC reports and often rely on smaller sample sizes.[](https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis) WHO's estimates prioritize health impacts but face criticism for under-sampling high-use populations due to reliance on voluntary national contributions.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/)\n\nRegional bodies like the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) provide detailed data for Europe, reporting 8.4% annual prevalence among adults aged 15–64 in 2023 based on harmonized surveys, which UNODC incorporates into global aggregates.[](https://www.euda.europa.eu/publications/european-drug-report/2025/cannabis_en) Similarly, the Inter-American Drug Abuse Control Commission (CICAD) compiles Americas-specific figures, but these feed into UNODC's framework rather than standing as independent global sources. Overall, UNODC's methodology emphasizes empirical triangulation to mitigate biases in self-reported data, such as underreporting in prohibitive legal environments, though absolute country rankings remain approximate due to survey non-comparability.\n\n### Survey Techniques and Comparability Issues\n\nSurveys measuring annual cannabis use prevalence primarily rely on self-reported data from nationally representative household surveys targeting the general population aged 15-64, which are considered reliable for estimating cannabis, amphetamine-type stimulants, and cocaine use due to respondents' willingness to disclose such behaviors compared to harder drugs.[](https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf) School-based surveys, such as the European School Survey Project on Alcohol and Other Drugs (ESPAD) or equivalents like the U.S. Monitoring the Future, capture data among 15- to 16-year-olds, with adjustments applied using regional benchmarks from countries like the United States, Colombia, and Pakistan to derive broader estimates.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf) Data aggregation occurs through mechanisms like the United Nations Office on Drugs and Crime (UNODC) Annual Report Questionnaire (ARQ), which compiles national survey results from member states, supplemented by regional bodies such as the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for Europe.[](https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf)\n\nAnnual prevalence is often derived indirectly from lifetime use data via regional conversion ratios—for instance, a ratio of 0.387 in West and Central Europe—due to inconsistencies in direct reporting across surveys.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf) Extrapolation techniques, including regression models or treatment-to-user multipliers, fill gaps where primary surveys are absent, particularly in low-response regions like Africa (57% ARQ participation) or Oceania (12.5%).[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf)\n\nComparability across countries is hindered by variations in survey design, including sampling frames that may exclude transient populations like the homeless or incarcerated, leading to underestimation in urban-heavy samples.[](https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf) Underreporting is prevalent due to social desirability bias, exacerbated in jurisdictions with strict prohibitions, where fear of legal repercussions suppresses disclosure, whereas legalized settings like parts of Canada or Uruguay yield higher reported rates.[](https://www.sciencedirect.com/science/article/abs/pii/S0955395912000758) Differences in question wording—such as defining \"use\" as any consumption versus repeated instances—and recall accuracy for the past-year period introduce further inconsistencies, with validity of estimates varying by national context and potentially biasing cross-country comparisons.[](https://www.sciencedirect.com/science/article/pii/S2666776221002131)\n\nTemporal mismatches arise from outdated data or disruptions like the COVID-19 pandemic, which halted surveys in 2020-2021 and affected response rates, while small nations (population under 100,000 aged 15-64) are often excluded from extrapolations to avoid distortion.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf) Heterogeneity in age standardization, response definitions (e.g., chronic versus occasional use), and reliance on indirect methods like wastewater analysis or seizure multipliers compounds uncertainty, with UNODC applying 10th-90th percentile ranges to quantify variability but noting persistent gaps in over 60 countries lacking recent household surveys.[](https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf)[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf)\n\n## Global and Regional Patterns\n\n### Worldwide Prevalence Overview\n\n![World map of countries by annual prevalence of cannabis use](./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png)\n\nIn 2023, an estimated 244 million people aged 15-64, or 4.6% of the global population in that age group, reported past-year cannabis use, making it the most prevalent illicit drug worldwide.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) This figure represents a one-third increase from the 3.9% prevalence recorded a decade earlier in 2013, reflecting rising consumption patterns amid expanding production and market diversification.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) Prevalence varies significantly by gender, with 7.0% of men and 2.3% of women reporting use in the past year.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf)\n\nRegional disparities underscore the global overview, with North America exhibiting the highest rates, followed by Oceania (Australia and New Zealand) and parts of West and Central Africa.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) Among adolescents aged 15-16, past-year use stood at 4.4% globally in 2023, comparable to adult rates but carrying heightened risks of cognitive and mental health impacts.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) These estimates, derived from surveys across 135 countries covering 70% of the world's population, highlight cannabis's dominance in treatment-seeking for drug use disorders, accounting for 42% of reporting countries' primary substance.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) However, underreporting remains a challenge in regions with strict prohibitions, potentially understating true prevalence in data-scarce areas like much of Asia and the Middle East.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf)\n\n### Regional Variations in Use Rates\n\n![World map of countries by annual prevalence of cannabis use](./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png)\n\nAnnual prevalence of cannabis use among adults aged 15-64 varies markedly across regions, with North America and Oceania exhibiting the highest rates globally. In North America, prevalence stands at approximately 20.2 percent, driven primarily by high use in the United States and Canada where legalization has coincided with increased accessibility.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html) Oceania follows closely, with rates around 12 percent overall, reflecting elevated use in Australia and New Zealand, where past-year prevalence exceeds 10 percent in national surveys.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html)\n\nEurope demonstrates moderate prevalence, averaging about 8 percent, though with subregional differences: Western and Central Europe report higher rates near 10 percent for men, while Eastern Europe tends lower.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html) [](https://www.euda.europa.eu/publications/european-drug-report/2025_en) In contrast, Asia records the lowest regional rates at roughly 1.5 percent, with male prevalence at 2.7 percent and female at 0.3 percent, attributed to strict prohibitions and cultural stigmas in many countries.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html)\n\nAfrica shows heterogeneous patterns, with West and Central subregions displaying higher prevalence—men at 10.9 percent—potentially linked to local production and traditional uses, while overall continental estimates hover around 6 percent.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html) South America averages 4.1 percent, lower than North America but with variations such as higher rates in Uruguay post-legalization.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html) These disparities underscore the influence of policy, enforcement, and socioeconomic factors on use patterns, though data comparability remains challenged by survey methodologies and underreporting in prohibitive contexts.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html)\n\n| Region          | Approximate Annual Prevalence (15-64, %) | Key Notes |\n|-----------------|------------------------------------------|-----------|\n| North America  | 20.2                                     | Highest globally; legalization impact |\n| Oceania        | ~12                                      | High in Australia/New Zealand |\n| Europe         | ~8                                       | Moderate, higher in West |\n| Africa         | ~6                                       | Elevated in West/Central subregions |\n| Asia           | ~1.5                                     | Lowest; strict controls |\n| South America  | 4.1                                      | Variable post-policy changes |[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html)\n\n## Country-Specific Rankings\n\n### Countries with Highest Reported Use\n\nThe countries with the highest reported annual cannabis use, based on general population surveys, are predominantly those with permissive cultural attitudes or legal frameworks, where self-reporting is less stigmatized. A 2024 systematic review and meta-analysis of studies from 2000 to 2024 identified peak rates exceeding 40% in select cases, though such figures derive from national household or population-based surveys prone to methodological variations, including differences in age groups sampled (typically 15-64 years) and question phrasing on past-year use. These outliers contrast with UNODC global estimates of around 4% annual prevalence, highlighting potential over-reporting in low-stigma environments versus under-reporting elsewhere due to legal risks.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/)\n\n![World map of countries by annual prevalence of cannabis use](./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png)\n\nReported highs cluster in Oceania, Western Europe, and North America. For instance, Australia recorded 48.70% past-year use in a 2004 national survey, reflecting broad accessibility and cultural normalization prior to subsequent declines amid policy shifts. The Netherlands followed with 43.90% in 2013, aligned with de facto tolerance in coffee shops, though subsequent European Monitoring Centre for Drugs and Drug Addiction data suggest stabilization around 10-15% in recent years due to tighter regulations. In North America, the United States reported 38.12% in 2021 National Survey on Drug Use and Health data for the population aged 12 and older, driven by state-level legalization expanding access, with daily use rising post-reform.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/)\n\n| Country | Reported Annual Prevalence | Year | Source Notes |\n|---------|----------------------------|------|--------------|\n| Australia | 48.70% | 2004 | National household survey; high due to low stigma[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/) |\n| Netherlands | 43.90% | 2013 | General population survey; tolerance policy context[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/) |\n| United States | 38.12% | 2021 | NSDUH, ages 12+; legalization effects[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/) |\n| Spain | 25.72% | 2010 | Regional variations; club-based access[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/) |\n| Brazil | 23.10% | 2019 | Urban-focused survey; rising trend[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/) |\n\nComparability remains challenged by survey timing and enforcement climates; for example, African nations like Nigeria report 19.4% (2019), potentially undercounted due to severe penalties, while UNODC regional modeling adjusts West Africa to around 9-10% overall. In Canada, post-2018 legalization surveys indicate 25-30% adult past-year use by 2023, exceeding pre-reform levels but below unadjusted self-reports in earlier liberal benchmarks. These patterns underscore causal links between reduced enforcement and elevated disclosure, rather than necessarily higher absolute consumption.[](https://worldpopulationreview.com/country-rankings/cannabis-use-by-country)\n\n### Countries with Lowest Reported Use\n\nSeveral nations in the Middle East and East Asia report annual cannabis use prevalence rates below 0.5% among adults aged 15-64, reflecting rigorous enforcement of prohibition laws, religious and cultural norms against intoxication, and societal pressures that discourage disclosure in surveys. Qatar records the lowest documented rate at 0.1%, followed by Saudi Arabia at 0.3%, based on aggregated national and regional data compilations. These figures likely underestimate true usage due to fear of legal repercussions—punishments in Saudi Arabia include flogging, imprisonment, or execution for drug offenses—leading to systematic underreporting in self-reported surveys, a common issue in authoritarian or theocratic regimes where data collection relies on voluntary admission rather than objective measures like wastewater analysis.[](https://worldpopulationreview.com/country-rankings/cannabis-use-by-country)\n\nIn East Asia, China, Japan, South Korea, Hong Kong, Vietnam, and Taiwan all report past-year prevalence under 0.5%, with China's total registered drug users (across all substances) numbering only 1.12 million in a population exceeding 1.4 billion as of 2022, implying cannabis-specific rates near negligible levels. Japan's illicit drug use remains low overall, with cannabis as the most prevalent but still affecting fewer than 1% annually, per government-monitored trends up to 2017 that show gradual increases yet retention of minimal baseline rates. These low reports align with zero-tolerance policies, such as Japan's three-year minimum sentence for possession and China's execution risks for trafficking, which prioritize deterrence over harm reduction and correlate with suppressed visibility of use. Peer-reviewed analyses confirm Asia's regional average at approximately 2%, far below global norms, though cross-national comparability is limited by varying survey methodologies and non-response biases in conservative societies.[](https://worldpopulationreview.com/country-rankings/cannabis-use-by-country)[](https://pubmed.ncbi.nlm.nih.gov/32009041/)\n\nOther examples include Malaysia, identified in comparative studies as having among the lowest prevalence and dependence rates in Southeast Asia, and Brunei, where Sharia-based prohibitions yield near-absent reported use amid capital penalties for trafficking. In the Islamic Republic of Afghanistan under Taliban rule since 2021, cultivation persists for export but domestic consumption is severely curtailed by public executions and destruction campaigns, resulting in de facto near-zero reported annual use despite historical highs pre-2021. Such patterns underscore causal links between draconian enforcement and visible restraint, though empirical evidence from indirect indicators like seizures suggests hidden consumption persists at low levels; for instance, UNODC data highlights Asia's overall cannabis user estimate at 54 million (2% prevalence) versus higher regional averages elsewhere. Credible sources like UNODC emphasize that these minima are not necessarily indicative of absolute rarity but of effective suppression of open use, with academic biases toward liberalization potentially downplaying enforcement efficacy in interpretations of the data.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/)\n\n### Key National Trends and Changes\n\nIn Canada, recreational cannabis legalization in October 2018 correlated with an initial rise in annual prevalence, with past-year use among those aged 15 and older increasing from 15% in 2018 to 22% by 2021, driven partly by reduced perceived risks and expanded access.[](https://www150.statcan.gc.ca/n1/daily-quotidien/231016/dq231016c-eng.htm) Subsequent national monitoring through 2024 shows stabilization in past-year rates alongside a modest uptick in past-30-day use to 17%, though daily or near-daily consumption edged higher from 7% pre-legalization to 8% post-legalization among workers.[](https://health-infobase.canada.ca/cannabis/)[](https://www.iwh.on.ca/plain-language-summaries/cannabis-use-by-workers-before-and-after-legalization-in-canada) These shifts reflect broader normalization, with heavier use patterns persisting among young adults aged 20-24, where prevalence exceeds 50% in some cohorts.[](https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-024-01112-9)\n\nIn the United States, the National Survey on Drug Use and Health (NSDUH) documents a substantial long-term increase in past-year cannabis use, rising from 11% in 2002 to 25% in 2022 among individuals aged 12 and older, with per capita rates doubling since 2008 amid progressive state-level decriminalization and commercialization.[](https://www.ncbi.nlm.nih.gov/books/NBK609482/)[](https://onlinelibrary.wiley.com/doi/10.1111/add.16519) Frequent use (daily or near-daily) among adults also climbed from 1.9% in 2002 to 3.5% by 2014, a trajectory that continued into the 2020s despite federal restrictions, as past-year prevalence reached 19% overall by 2023 estimates.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8905582/)[](https://www.cdc.gov/cannabis/data-research/facts-stats/index.html) Youth trends show volatility, with past-year use among adolescents increasing from 7.6% in 2013 to 15.1% in 2022 before plateauing.[](https://www.sciencedirect.com/science/article/pii/S2772724624000374)\n\nAcross Europe, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reports steady growth in cannabis prevalence, with last-year use estimated at 8.4% among adults aged 15-64 in recent national surveys, and past-month use up 27% from 2010 to 2019 levels at 3.9%.[](https://www.euda.europa.eu/publications/european-drug-report/2025/cannabis_en)[](https://www.sciencedirect.com/science/article/pii/S2666776221002131) Among young adults aged 15-34, last-year prevalence hovered at 15.1% as of 2023, with males twice as likely to report use, though country variations persist—higher in nations like Spain and France, lower in Eastern Europe.[](https://www.euda.europa.eu/publications/european-drug-report/2023/cannabis_en) These increments align with rising potency and market availability, despite uneven policy reforms.[](https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762%2821%2900213-1/fulltext)\n\nGlobally, United Nations Office on Drugs and Crime (UNODC) data indicate cannabis remains the most prevalent illicit substance, with 219 million past-year users (4.3% of adults) in 2021, up from prior estimates, though 44% of reporting countries noted stable rates between surveys.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf)[](https://docs.un.org/en/E/CN.7/2023/CRP.18) Increases predominate in legalized or tolerant jurisdictions, while prohibitionist regions like parts of Asia and the Middle East sustain low prevalence below 1%, with minimal documented shifts due to enforcement and cultural stigma.[](https://worldpopulationreview.com/country-rankings/cannabis-use-by-country)\n\n## Factors Influencing Prevalence\n\n### Legal Policy Effects on Use Rates\n\nEmpirical studies on jurisdictions transitioning from prohibition or decriminalization to regulated recreational cannabis markets indicate that legal policy changes have generally resulted in modest or negligible shifts in overall annual prevalence rates, with variations by age group and timeframe. In the United States, where 24 states had legalized recreational use by 2023, meta-analyses of state-level data from 2012 onward show small increases in past-month adult use (approximately 1-2 percentage points) following implementation, but no consistent rise in youth prevalence; for instance, Monitoring the Future surveys reported stable or declining adolescent use rates post-legalization in states like Colorado and Washington.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/)[](https://pubmed.ncbi.nlm.nih.gov/38552901/) These findings suggest that pre-existing upward trends in use, driven by shifting attitudes, accounted for much of the observed change rather than policy alone.[](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8253-4)\n\nCanada's national legalization in October 2018 provides a controlled national case, where past-year cannabis use among adults aged 15 and older rose slightly from 15% in 2018 to 17% by 2024, aligning with a 2-3% increase in past-30-day use, though rates stabilized after 2020 and remained below peaks in some subgroups.[](https://health-infobase.canada.ca/cannabis/) Longitudinal data indicate this increment continued a pre-legalization trajectory of rising use from 2013-2017, with no evidence of exponential growth; youth use (ages 15-24) showed minimal change, hovering around 20-25% past-year prevalence.[](https://www.sciencedirect.com/science/article/pii/S0955395924000707) In Uruguay, the world's first nation to fully legalize recreational cannabis in 2013, annual prevalence remained stable at 7-9% through 2022, with problematic use fixed at 2.1% since 2011 and overall consumption declining from 14.6% in 2018 to 12.3% by 2024 among surveyed populations, attributed partly to regulated supply reducing unregulated access.[](https://internationalcbc.com/did-cannabis-usage-rates-spike-in-uruguay-and-canada-post-legalization/)\n\nDecriminalization without full commercialization, as in Portugal since 2001, correlates with sustained low prevalence; lifetime cannabis use among adults fell from 7.8% in 2001 to 5.9% by 2019, alongside reduced treatment admissions, challenging assumptions that laxer policies inherently drive uptake.[](https://www.sciencedirect.com/science/article/pii/S0955395925000957) Conversely, stringent prohibition in countries like Singapore yields reported annual rates below 1%, but surveys likely undercount due to severe penalties (up to 10 years imprisonment for possession), illustrating enforcement's role in suppressing visibility rather than eliminating demand.[](https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2024.116) Systematic reviews emphasize that policy effects are heterogeneous, with modest positive associations for young adult initiation (odds ratio ~1.1-1.3) but limited causal impact on heavy use, as access barriers under prohibition fail to deter determined users while fostering black markets.[](https://bmjopen.bmj.com/content/9/7/e025880)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10036775/)\n\n| Jurisdiction | Policy Change | Pre-Change Annual Prevalence (%) | Post-Change Annual Prevalence (%) | Key Notes |\n|--------------|---------------|----------------------------------|-----------------------------------|-----------|\n| Canada (National) | Recreational legalization (2018) | 15 (2018) | 17 (2024, adults 15+) | Slight rise, trend continuation; youth stable.[](https://health-infobase.canada.ca/cannabis/) |\n| Uruguay (National) | Recreational legalization (2013) | ~8 (2011) | ~8 (2022) | Stable overall; problematic use unchanged.[](https://internationalcbc.com/did-cannabis-usage-rates-spike-in-uruguay-and-canada-post-legalization/) |\n| Colorado, USA (State) | Recreational legalization (2012) | 12.3 (2011, past-year adults) | 13.6 (2015) | Modest adult increase; youth no change.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/) |\n| Portugal (National) | Decriminalization (2001) | 7.8 lifetime (2001) | 5.9 lifetime (2019) | Decrease post-policy; low enforcement focus.[](https://www.sciencedirect.com/science/article/pii/S0955395925000957) |\n\nThese patterns underscore that legal policies influence reported access and normalization more than underlying demand, with no jurisdiction exhibiting the dramatic surges predicted by deterrence models; instead, prevalence aligns closely with cultural and socioeconomic drivers. Peer-reviewed evidence tempers claims from advocacy sources overstating either harms or benefits, highlighting the need for longitudinal controls to isolate policy from secular trends.[](https://www.nber.org/system/files/working_papers/w28647/w28647.pdf)[](https://pubmed.ncbi.nlm.nih.gov/38552901/)\n\n### Cultural, Economic, and Demographic Drivers\n\nCultural attitudes toward cannabis, shaped by religious doctrines and historical traditions, exert substantial influence on national prevalence rates. In predominantly Islamic countries, where religious texts interpret cannabis as an intoxicant prohibited under Sharia law, annual use remains minimal, often below 1% in nations like Saudi Arabia and Iran, as doctrinal enforcement suppresses both production and consumption. Conversely, in Hindu-majority India, cannabis derivatives such as bhang hold sacramental roles in rituals associated with Shiva worship, contributing to a cultural tolerance that sustains moderate prevalence around 3% among adults, though recreational use is less widespread than in Western contexts.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6153265/)[](https://link.springer.com/article/10.1007/s40429-023-00500-8) These patterns underscore how entrenched cultural norms, independent of legal status, can either entrench stigma or foster acceptance, with secular Western societies exhibiting higher rates due to diminished religious opposition to psychoactive substances.\n\nEconomic factors, particularly national wealth, correlate positively with cannabis use in cross-national analyses of youth. A study across 31 European and North American countries identified higher GDP per capita as associated with increased frequent use among mid-adolescents, attributing this to greater disposable income facilitating access and social experimentation in affluent settings. However, this trend contrasts with intra-country data from the United States, where lower-income groups report higher usage rates, suggesting that at the global level, prosperity enables recreational rather than coping-driven consumption, while poverty in developing regions may amplify use through informal markets despite lower overall reporting. African nations like Nigeria, with 19.4% prevalence despite modest GDP, illustrate how economic informality and agricultural production can sustain high rates amid underinvestment in alternatives.[](https://www.researchgate.net/publication/7327496_Economic_and_cultural_correlates_of_cannabis_use_among_mid-adolescents_in_31_countries)[](https://worldpopulationreview.com/country-rankings/cannabis-use-by-country)\n\nDemographic variables, including gender, age structure, and urbanization, systematically shape prevalence disparities. Globally, males exhibit nearly three times the annual use rate of females, as documented in UNODC estimates, reflecting biological, social, and risk-taking differences amplified across cultures. Youth-dominated populations drive higher national figures, with peak use in the 15-34 age cohort, as older groups show sharp declines; countries with bulging youth demographics, such as those in sub-Saharan Africa, thus report elevated averages despite data inconsistencies. Urbanization further elevates rates, with urban dwellers facing heightened exposure through dense social networks and availability, as evidenced in European contexts where city prevalence exceeds rural by factors of 1.5-2, a pattern linked to migration and lifestyle shifts rather than policy alone.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/)[](https://econtent.hogrefe.com/doi/10.1024//1421-0185.60.2.99)\n\n## Data Limitations and Debates\n\n### Sources of Underreporting and Bias\n\nSelf-reported surveys, which form the basis of most international cannabis prevalence estimates, systematically underestimate actual use due to respondents' reluctance to disclose illicit behavior. Validation studies using biological markers such as hair assays reveal that self-reports underreport substance use prevalence by 30% to 60%, with an average detection ratio of 1.50 when compared to objective tests.[](https://www.sciencedirect.com/science/article/pii/S089085672300045X) For cannabis specifically, discrepancies arise when users report alternative forms like blunts without acknowledging cannabis content, leading to adjusted past-year prevalence estimates rising from reported figures to 15.5% in some national samples.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8720324/)\n\nLegal status exacerbates underreporting in countries where cannabis remains prohibited, as fear of legal consequences prompts non-disclosure or survey non-response. In jurisdictions with harsh penalties, respondents anticipate prosecution risks, even in anonymous surveys, resulting in lower reported rates compared to legalized regions where disclosure barriers diminish.[](https://journals.sagepub.com/doi/abs/10.1080/08897077.2021.1941520) Criminalization frameworks amplify this effect by fostering perceptions of use as inherently deviant, correlating with diminished self-reporting across global datasets compiled by bodies like the UNODC.[](https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf)\n\nCultural stigma compounds these issues, particularly in conservative or collectivist societies where admitting drug use invites social ostracism or familial repercussions, independent of legal risks. Stigma-driven underreporting manifests in reduced treatment-seeking and survey participation, with international comparisons showing higher discrepancies in regions prioritizing moralistic views over harm reduction.[](https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-020-00288-0) Methodological biases further distort data; for instance, interview mode influences candor, with telephone surveys yielding higher underreporting among certain demographics due to perceived lower anonymity.[](https://www.researchgate.net/publication/249278027_Diminished_Lifetime_Substance_Use_Over_Time_An_Inquiry_Into_Differential_Underreporting)\n\nInternational statistics exhibit regional biases, with more reliable data from Western Europe and North America—where EMCDDA and similar agencies employ standardized, anonymous protocols—contrasting sparse or manipulated reports from authoritarian states or low-resource areas. In policy-restrictive environments, governments may suppress or fabricate low-use figures to align with anti-drug narratives, while post-legalization shifts in perception reduce stigma but introduce overreporting risks from normalized attitudes.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/) These asymmetries privilege empirical data from high-credibility sources like peer-reviewed validations over unverified national claims, highlighting the need for biomarker corroboration in global rankings.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4897110/)\n\n### Implications for Policy and Interpretation\n\nData on annual cannabis prevalence reveal that countries enforcing strict prohibition, such as those in the Middle East and parts of Asia, consistently report rates below 1%, suggesting effective deterrence through severe penalties and cultural stigma when enforcement is rigorous.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html) In contrast, nations with legalization or decriminalization, including Canada and Uruguay, have observed post-reform increases in adult use, with Canada's past-year prevalence rising from approximately 15% pre-2018 to over 20% by 2021, alongside accelerated daily use patterns.[](https://www.unodc.org/unodc/frontpage/2022/June/unodc-world-drug-report-2022-highlights-trends-on-cannabis-post-legalization--environmental-impacts-of-illicit-drugs--and-drug-use-among-women-and-youth.html) [](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15883-6) These trends imply that policy liberalization correlates with normalized consumption among adults, potentially eroding perceptions of harm, as evidenced by declining risk assessments in legalized U.S. states.[](https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf)\n\nPolicy formulation must account for causal factors beyond legality, including enforcement capacity and sociocultural norms; empirical evidence indicates prohibition suppresses prevalence more reliably in homogeneous societies with low tolerance for intoxicants, whereas Western contexts show modest use upticks post-legalization without corresponding youth surges.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/) Decriminalization models, like Portugal's, have not demonstrably reduced cannabis-specific prevalence compared to stricter regimes, highlighting that supply regulation may mitigate black-market harms but invites higher potency products and treatment demands.[](https://www.sciencedirect.com/science/article/pii/S2468266724002998) [](https://www.ccjm.org/content/92/7/407) Thus, blanket legalization risks amplifying public health burdens, such as increased healthcare utilization, absent targeted interventions like age restrictions and education.[](https://www.healthaffairs.org/do/10.1377/hpb20210701.500845/)\n\nInterpreting rankings requires caution due to methodological variances; self-reported surveys in prohibitive jurisdictions likely understate true use owing to stigma-induced non-disclosure, while liberal environments yield more candid data, potentially inflating comparative prevalence.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html) Cross-national analyses must disentangle policy effects from confounders like economic prosperity and youth demographics, as higher-use nations often feature urbanized, affluent populations predisposed to experimentation.[](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15883-6) Policymakers interpreting these disparities should prioritize evidence of enforcement efficacy over ideological shifts toward permissiveness, recognizing that sustained low prevalence under prohibition underscores viable alternatives to commodification.[](https://www.sciencedirect.com/science/article/pii/S0955395925000957)[](https://www.tni.org/files/publication-downloads/icsdp-cannabis_report.pdf)"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761886942710,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"World Drug Report 2025\",\"description\":\"No readable text found in the HTML.\u003c|separator|\u003e\",\"url\":\"https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"[PDF] World Drug Report 2025 - UNODC\",\"description\":\"Jun 13, 2025 · ANNUAL PREVALENCE OF DRUG USE, BY DRUG AND BY REGION, 2023. GLOBAL NUMBER OF PEOPLE WHO USE DRUGS AND PREVALENCE OF DRUG USE,. 2013, 2018 AND ...\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"Prevalence of Cannabis Use around the World: A Systematic ... - NIH\",\"description\":\"Jun 21, 2024 · The prevalence of cannabis use varied between 0.42% and 43.90% across 33 European countries, 1.40% to 38.12% across 15 North and South American countries.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11196877/\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"[PDF] World Drug Report 2025 Methodological Annex\",\"description\":\"The use of annual prevalence is a compromise between lifetime prevalence data (drug use at least once in a lifetime) and data on current use (drug use at ...\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"dp-drug-use-prevalence - dataUNODC |\",\"description\":\"Prevalence of Drug Use in the General Population (excluding NPS). Annual Prevalence of Use as a percentage of the population aged 15-64 (unless otherwise ...\",\"url\":\"https://dataunodc.un.org/dp-drug-use-prevalence\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"[PDF] Metadata Information Drug Use and Treatment - Data UNODC\",\"description\":\"Jun 26, 2025 · The annual prevalence (past year prevalence) refers ... Data on prevalence of drug use are produced mostly based on household surveys (with.\",\"url\":\"https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"Public health monitoring of cannabis use in Europe - NIH\",\"description\":\"Sep 24, 2021 · Two types of cannabis indicators are obtained for: prevalence of use, defined as any use in the past year or past month; and high-risk use, ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8589728/\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"UNODC World Drug Report 2025: Global instability compounding ...\",\"description\":\"Jun 26, 2025 · This edition of the World Drug Report shows that organized drug trafficking groups continue to adapt, exploit global crises, and target vulnerable populations.\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"World Drug Report 2025 - Unodc\",\"description\":\"World Drug Report 2025. PreviousNext. A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and ...Drug market patterns and trends · Key findings · Special Points of Interest · Maps\",\"url\":\"https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"Cannabis - World Health Organization (WHO)\",\"description\":\"About 147 million people, 2.5% of the world population, consume cannabis (annual prevalence) compared with 0.2% consuming cocaine and 0.2% consuming opiates. ...\",\"url\":\"https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"Cannabis – the current situation in Europe (European Drug Report ...\",\"description\":\"Jun 5, 2025 · Cannabis is the most widely consumed illicit drug in Europe, with national surveys showing that an estimated 8.4 % of European adults (24 million aged 15 to 64 ...\u003c|separator|\u003e\",\"url\":\"https://www.euda.europa.eu/publications/european-drug-report/2025/cannabis_en\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"[PDF] World Drug Report 2021 Methodological Annex - Unodc\",\"description\":\"For example, it is generally accepted that nationally representative household surveys are reasonably good approaches to estimating cannabis, ATS or cocaine use ...\",\"url\":\"https://www.unodc.org/res/wdr2021/field/WDR-2021-Methodology.pdf\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"Are cannabis prevalence estimates comparable across countries ...\",\"description\":\"Prevalence estimation of cannabis use is usually based on survey data. The resulting estimates are regularly compared across countries without having detailed ...Missing:  challenges | Show results with:challenges\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0955395912000758\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"Public health monitoring of cannabis use in Europe: prevalence of ...\",\"description\":\"We estimate that in 2019, 3.9% of European adults aged 15 to 64 have used cannabis use in the past month – an increase of 27% against 2010 levels.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2666776221002131\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"European Drug Report 2025: Trends and Developments\",\"description\":\"Jun 6, 2025 · On this page, you can find the latest analysis of the drug situation for cannabis in Europe, including prevalence of use, treatment demand, ...The drug situation in Europe... · Cannabis · Drug supply, production and... · MDMA\",\"url\":\"https://www.euda.europa.eu/publications/european-drug-report/2025_en\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"Cannabis Use by Country 2025 - World Population Review\",\"description\":\"Countries in Africa have relatively high cannabis usage, with three countries - Ghana (21.5% as of 1998), Nigeria (19.4% as of 2019), and Zambia (14.8 as of ...\",\"url\":\"https://worldpopulationreview.com/country-rankings/cannabis-use-by-country\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"[Current Situation of Cannabis Use in Japan: Based on Data from ...\",\"description\":\"In 2017, about 1.3 million people were cannabis users in Japan, with use increasing between 2015 and 2017. It became the most abused drug in Japan.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/32009041/\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Current state of cannabis use, policies, and research across sixteen ...\",\"description\":\"A higher prevalence of cannabis use or dependence was found among teenagers or younger adults than among elderly adults in European (Italy, Spain), African ( ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9490942/\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"Five years since legalization, what have we learned about cannabis ...\",\"description\":\"Oct 16, 2023 · After legalization, cannabis use is higher​​ In 2021, 22% of Canadians aged 15 years and older reported using cannabis in the past year. The ...\",\"url\":\"https://www150.statcan.gc.ca/n1/daily-quotidien/231016/dq231016c-eng.htm\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Key findings: Cannabis use in Canada (2023) - Health Infobase\",\"description\":\"Dec 6, 2024 · Past 30-day cannabis use increased from 15% in 2018 to 17% in 2024, but was unchanged from 17% in 2023.Data over the past 7 years · Cannabis use for non-medical... · Cannabis sourcing\",\"url\":\"https://health-infobase.canada.ca/cannabis/\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"Cannabis use by workers before and after legalization in Canada\",\"description\":\"Daily use or near-daily use also increased from 7.0 per cent pre-legalization to 8.0 per cent after legalization, a statistically significant but modest change.\",\"url\":\"https://www.iwh.on.ca/plain-language-summaries/cannabis-use-by-workers-before-and-after-legalization-in-canada\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"Reducing the harms of cannabis use in youth post-legalization\",\"description\":\"Nov 6, 2024 · Canada has one of the highest prevalence of cannabis use globally, particularly among young adults aged 20–24 (50%) and youth aged 16–19 (37%).\",\"url\":\"https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-024-01112-9\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"Cannabis Consumption and Markets in the United States - NCBI - NIH\",\"description\":\"By 2022, this figure had grown to 21.9 percent. While overall prevalence has increased, differences are evident by age, sex, race or ethnicity, and other ...Missing:  regional | Show results with:regional\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK609482/\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"Changes in self‐reported cannabis use in the United States from ...\",\"description\":\"May 22, 2024 · This study aimed to measure long-term trends in cannabis use in the United States and compare them with alcohol use.\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1111/add.16519\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"Trends over time in adult cannabis use: A review of recent findings\",\"description\":\"In addition, the prevalence of frequent cannabis use (daily or near-daily) increased from 1.9% in 2002 to 3.5% in 2014 among adults aged 18 years and older, ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8905582/\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"Cannabis Facts and Stats - CDC\",\"description\":\"Mar 7, 2025 · Cannabis is the most commonly used federally illegal drug in the United States; 52.5 million people, or about 19% of Americans, used it at least ...Missing:  country | Show results with:country\",\"url\":\"https://www.cdc.gov/cannabis/data-research/facts-stats/index.html\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"Prevalence of and trends in current cannabis use among US youth ...\",\"description\":\"Cannabis use increased from 7.59% to 11.48% in 2013-2019, was 11.54% in 2020, and increased again from 13.13% to 15.11% in 2021-2022.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2772724624000374\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"Cannabis – the current situation in Europe (European Drug Report ...\",\"description\":\"Jun 16, 2023 · Last year cannabis use among the EU population aged 15 to 34 is estimated at 15.1 % (15.3 million), with males being typically twice as likely ...\",\"url\":\"https://www.euda.europa.eu/publications/european-drug-report/2023/cannabis_en\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"prevalence of use, cannabis potency, and treatment rates - The Lancet\",\"description\":\"Sep 23, 2021 · There is a considerable variation in prevalence of use, ranging from 9·1% in Spain to less than 1% in Malta, Hungary, and Turkey. Approximately ...\",\"url\":\"https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762%2821%2900213-1/fulltext\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"[PDF] World Drug Report 2023 - UNODC\",\"description\":\"Among all countries that ranked the drugs leading to drug use disorders, the majority. (46 per cent of countries) reported cannabis in first place, 31 per cent ...\",\"url\":\"https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"[PDF] Progress made in the implementation of all international drug policy ...\",\"description\":\"Nov 27, 2023 · While 39.5 million people worldwide were suffering from drug use disorders in 2021, according to the WDR 2023, only one in five received drug ...\u003c|separator|\u003e\",\"url\":\"https://docs.un.org/en/E/CN.7/2023/CRP.18\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"The Impact of Recreational Cannabis Legalization on ... - NIH\",\"description\":\"May 9, 2023 · Comparison studies found evidence of some increase in cannabis use 12 months after RCL. Past year cannabis use rates started increasing prior to ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10176789/\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"Systematic Review and Meta-Analysis: Medical and Recreational ...\",\"description\":\"Our meta-analytic results showed modest positive effects of RCL on past-month cannabis use (more so in young adults than in adolescents) and minimal effects of ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/38552901/\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"Marijuana legalization and historical trends in marijuana use among ...\",\"description\":\"Feb 4, 2020 · The estimated cohort effect showed a historical decline in marijuana use in those who were born in 1954–1972, a sudden increase in 1972–1984, ...\",\"url\":\"https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8253-4\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"How have cannabis use and related indicators changed since ...\",\"description\":\"This paper examined trends in use of cannabis for non-medical purposes and related indicators from pre- to post-legalization in Canada (2018–2022).\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0955395924000707\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"Did Cannabis Usage Rates Spike In Uruguay And Canada...\",\"description\":\"May 14, 2025 · 'Problematic use' has remained steady at 2.1% since 2011 · Overall consumption rates fell from 14.6% in 2018 to 12.3% in 2024 · The average age of ...\",\"url\":\"https://internationalcbc.com/did-cannabis-usage-rates-spike-in-uruguay-and-canada-post-legalization/\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"A review of international research on the outcomes of regulated ...\",\"description\":\"We reviewed studies on the outcomes of regulated cannabis supply for adult use in the Netherlands, Spain, U.S. states, Uruguay, and Canada.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0955395925000957\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"Prevalence of Cannabis Use around the World - China CDC Weekly\",\"description\":\"Jun 21, 2024 · The prevalence of cannabis use varied between 0.42% and 43.90% across 33 European countries, 1.40% to 38.12% across 15 North and South American countries.\",\"url\":\"https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2024.116\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"Does liberalisation of cannabis policy influence levels of use in ...\",\"description\":\"Our systematic review and meta-analysis suggest a small increase in cannabis use among adolescents and young adults following legalisation of cannabis for ...\",\"url\":\"https://bmjopen.bmj.com/content/9/7/e025880\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"Impacts of recreational cannabis legalization on use and harms - NIH\",\"description\":\"For example, one recent systematic review that identified 32 relevant studies found that legalization was associated with an increase in past-month cannabis use ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10036775/\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"[PDF] The public health effects of legalizing marijuana\",\"description\":\"Producing accurate, unbiased estimates of the effects of marijuana legalization is of obvious importance to the making of sound policy. For instance, although ...\u003c|separator|\u003e\",\"url\":\"https://www.nber.org/system/files/working_papers/w28647/w28647.pdf\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"Islam and cannabis: Legalisation and religious debate in Iran - PMC\",\"description\":\"The article engages with the question of cannabis by looking at the legal interpretation of religious authorities in the Islamic Republic of Iran. The choice of ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6153265/\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"a Descriptive Overview of Cannabis Use across Cultures\",\"description\":\"Jun 30, 2023 · For instance, patterns of cannabis use in Anglo-American countries (Canada, the UK, and the USA) showed higher prevalence estimates relative to ...\",\"url\":\"https://link.springer.com/article/10.1007/s40429-023-00500-8\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"Economic and cultural correlates of cannabis use among mid ...\",\"description\":\"Jul 21, 2020 · This study found that in wealthier countries across Europe and North America, young people used cannabis more frequently, potentially resulting ...\",\"url\":\"https://www.researchgate.net/publication/7327496_Economic_and_cultural_correlates_of_cannabis_use_among_mid-adolescents_in_31_countries\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"Cannabis use in Switzerland: The role of attribution of drug use to ...\",\"description\":\"Cannabis use does not show homogeneous patterns in a country. In particular, urbanization appears to influence prevalence rates, with higher rates in urban ...Missing:  global | Show results with:global\u003c|separator|\u003e\",\"url\":\"https://econtent.hogrefe.com/doi/10.1024//1421-0185.60.2.99\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"When Substance Use Is Underreported: Comparing Self-Reports ...\",\"description\":\"Self-reports underestimated the prevalence of most substances by 30% to 60% compared to hair tests. The average detection ratio (hair test/self-report) was 1.50 ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S089085672300045X\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"Underreporting of past-year cannabis use on a national survey ... - NIH\",\"description\":\"4.8% of people who reported blunt use did not report cannabis use, suggesting underreporting. Accounting for this, cannabis use increased to 15.5%.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8720324/\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"Underreporting of Past-Year Cannabis use on a National Survey by ...\",\"description\":\"Jan 1, 2022 · We compared self-reported prevalence of past-year cannabis use and blunt use and delineated correlates of underreporting cannabis use, defined ...\",\"url\":\"https://journals.sagepub.com/doi/abs/10.1080/08897077.2021.1941520\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"[PDF] DRUG MARKET TRENDS CANNABIS OPIOIDS - Unodc\",\"description\":\"Jun 11, 2022 · with most users found in Asia and North America ... and Middle East and Africa; and the northern route includes Central Asia, Eastern Europe and ...\",\"url\":\"https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"Stigma: how it affects the substance use disorder patient\",\"description\":\"Jul 27, 2020 · The stigma surrounding individuals who have substance use disorders is a pervasive phenomenon that has had detrimental effects on treatment outcomes.\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-020-00288-0\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"Diminished Lifetime Substance Use Over Time: An Inquiry Into ...\",\"description\":\"Aug 5, 2025 · The most consistent correlates of underreporting were interview mode, race/ethnicity, and educational status. Those interviewed by telephone, ...\u003c|separator|\u003e\",\"url\":\"https://www.researchgate.net/publication/249278027_Diminished_Lifetime_Substance_Use_Over_Time_An_Inquiry_Into_Differential_Underreporting\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"Sources of Error in Substance Use Prevalence Surveys - PMC - NIH\",\"description\":\"Other research has employed urinalysis [227] and hair assays [228] to document drug use frequency underreporting among drug users receiving treatment.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4897110/\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"World Drug Report 2024 - Unodc\",\"description\":\"A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several ...Key findings and conclusions · Drug market patterns and trends · Statistical Annex\",\"url\":\"https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"UNODC World Drug Report 2022 highlights trends on cannabis post ...\",\"description\":\"Jun 27, 2022 · Cannabis legalization in parts of the world appears to have accelerated daily use and related health impacts, according to the UN Office on Drugs and Crime ( ...\",\"url\":\"https://www.unodc.org/unodc/frontpage/2022/June/unodc-world-drug-report-2022-highlights-trends-on-cannabis-post-legalization--environmental-impacts-of-illicit-drugs--and-drug-use-among-women-and-youth.html\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"Trends of cannabis use and related harms before and after ...\",\"description\":\"May 19, 2023 · The prevalence of cannabis use in the past year had increased from 2.2% in 2019 to 2.5% and 4.2% in 2020 and 2021 respectively, while those of ...\",\"url\":\"https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15883-6\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"The adverse public health effects of non-medical cannabis ...\",\"description\":\"In this paper, we summarise the evidence to date on the legalisation of adult non-medical cannabis use in Canada and the USA.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2468266724002998\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"Recreational cannabis legalization: Potential implications for ...\",\"description\":\"Jul 1, 2025 · Legalization may increase consumption, cannabis use disorder, and healthcare visits. Some studies suggest increased traffic collisions and ...\",\"url\":\"https://www.ccjm.org/content/92/7/407\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"Cannabis Legalization In The US: Population Health Impacts\",\"description\":\"Jul 1, 2021 · In this brief, we summarize research on how cannabis legalization relates to use of the substance and key population health outcomes.\",\"url\":\"https://www.healthaffairs.org/do/10.1377/hpb20210701.500845/\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"[PDF] US Federal Government Data on Cannabis Prohibition\",\"description\":\"While it has been argued that rates of cannabis use would be higher if strict criminal penalties were not in place, this argument is inconsistent with available ...\",\"url\":\"https://www.tni.org/files/publication-downloads/icsdp-cannabis_report.pdf\",\"favicon\":\"\"}],\"images\":[{\"id\":\"9a3d3fcc3cf2\",\"caption\":\"World map of countries by annual prevalence of cannabis use\",\"url\":\"./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"9a3d3fcc3cf2\",\"caption\":\"World map of countries by annual prevalence of cannabis use\",\"url\":\"./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"9a3d3fcc3cf2\",\"caption\":\"World map of countries by annual prevalence of cannabis use\",\"url\":\"./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"9a3d3fcc3cf2\",\"caption\":\"World map of countries by annual prevalence of cannabis use\",\"url\":\"./_assets_/World_map_of_countries_by_annual_prevalence_of_cannabis_use.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0}],\"fixedIssues\":[],\"slug\":\"List_of_countries_by_annual_cannabis_use\",\"title\":\"List of countries by annual cannabis use\",\"content\":\"$1f\",\"description\":\"List of countries by annual cannabis use\\n\\nWorld map of countries by annual prevalence of cannabis use\\nThe list of countries by annual cannabis use enumerates nations according to the estimated...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761583339\",\"contentLength\":\"42524\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"77847\",\"recentViews\":\"77847\",\"dailyAvgViews\":2594.89990234375,\"qualityScore\":1,\"lastViewed\":\"1761886942\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761886942707,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"List_of_countries_by_annual_cannabis_use\"],\"queryHash\":\"[\\\"page\\\",\\\"List_of_countries_by_annual_cannabis_use\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"List of countries by annual cannabis use\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/List_of_countries_by_annual_cannabis_use\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"List of countries by annual cannabis use\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/List_of_countries_by_annual_cannabis_use\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"List of countries by annual cannabis use\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:43.339Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"List of countries by annual cannabis use\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"The list of countries by annual cannabis use enumerates nations according to the estimated proportion of their adult population—typically those aged 15 to 64—who report having used cannabis at least once in the previous 12 months. These figures stem from self-reported responses in national population-based surveys, aggregated and harmonized by the United Nations Office on Drugs and Crime (UNODC) through its World Drug Reports to facilitate international comparability, though methodological...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MGM0MzllOTctNGY0YS00ZTg1LThkZDMtNzYzYWQ4M2MwMDY0">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"List_of_countries_by_annual_cannabis_use\"}]}]\n"])</script></body></html>